Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Effectiveness of Different Dosage of Neostigmine in Combination with Metoclopramide on Gastric Residual Volume
IRCT20170903036041N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of neostigmine and metoclopramide in None, sponsored by Iran University of Medical Sciences. Started Jun 2017; status: completed.
02
Drugs
neostigminemetoclopramide
Beyond the preview
Go deeper on IRCT20170903036041N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170903036041N1.